lucitanib
Showing 1 - 8 of 8
Advanced Solid Tumor, Gynecologic Cancer Trial in Worldwide (Lucitanib, Nivolumab)
Suspended
- Advanced Solid Tumor
- Gynecologic Cancer
- Lucitanib
- Nivolumab
-
Los Angeles, California
- +26 more
Dec 16, 2022
Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)
Withdrawn
- Carcinoma, Non-small Cell Lung Cancer
- nivolumab
- +5 more
-
Detroit, Michigan
- +22 more
Mar 8, 2022
Solid Tumors Trial in France, Italy, Spain (Lucitanib)
Completed
- Solid Tumors
- Lucitanib
-
Villejuif, Paris, France
- +3 more
Jan 2, 2020
Breast Cancer Trial in Worldwide (lucitanib)
Completed
- Breast Cancer
- lucitanib
-
East Melbourne, Australia
- +28 more
Jan 2, 2020
NSCLC, Squamous NSCLC, NSCLC Trial in Worldwide (Lucitanib)
Terminated
- Non-Small Cell Lung Cancer
- +8 more
- Lucitanib
-
Los Angeles, California
- +18 more
Jul 22, 2019
Advanced Cancer Trial in La Jolla (Lucitanib)
Withdrawn
- Advanced Cancer
- Lucitanib
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Jul 31, 2018
Advanced Solid Tumors Trial in Shanghai (Lucitanib)
Completed
- Advanced Solid Tumors
- Lucitanib
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 14, 2017